Abstract
BackgroundIndividuals with head and neck squamous cell carcinoma (HNSCC) not associated with human papillomavirus (HPV) experience high rates of recurrence and poor survival. Clinical studies suggest that neoadjuvant immune checkpoint...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
